739500login-checkIn Primate Study, Antibody Treatment Prevents Organ Rejection After Transplant |
By Cara Murez HealthDay Reporter
THURSDAY, Aug. 31, 2023 (HealthDay News) — A new study in non-human primates shows potential for using a manmade monoclonal antibody to help prevent organ rejection after a transplant.
The antibody was successful in promoting graft survival after kidney and pancreatic islet cell transplantations, according to the research.
This clears a path for this new monoclonal antibody to move forward in human clinical trials, the researchers said. Read more in U.S. News & World Report.
739500login-checkIn Primate Study, Antibody Treatment Prevents Organ Rejection After Transplant |